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Abstract
Background: Equity remains a priority in the international health development agenda. However, major inequities
in vaccination coverage jeopardise the achievement of the Sustainable Development Goals. We aim at
comprehensively describing how research has addressed equity issues related to vaccination.
Methods: We carried out an overview of systematic reviews (SRs) that explicitly explored the effects of
interventions to improve vaccination in any context; for any vaccine and, in any language. We followed standard
research synthesis methods to systematically search for SR, assess them for inclusion and extracting relevant data,
particularly on vaccination related outcomes. To gather evidence on equity issues addressed in the SR, we used the
PROGRESS-plus framework.
Findings: Our search obtained 2,003 hits which resulted in 54 included SRs, published between 1994 and 2014.
The quality of SRs was generally poor, with less than half complying with most of the quality criteria. Reported
vaccines included, by order of frequency, influenza and Expanded Programme on Immunisation vaccines. The
types of interventions more frequently reported were related to vaccination delivery strategies, financial support
and information, education and communication. Most of the SRs suggested effects favouring intervention groups
as opposed to comparison groups. The most frequently reported equity attribute was ‘place of residence’ and the
least reported equity attributes were sexual orientation and religion. Very few estimates of effects actually measured
differences or changes between groups having those attributes and all of them referred to the place of residence.
No data was found about reducing equity gaps for vulnerable groups or minorities, or attributes such as sexual
orientation, education or specific religious groups.
Conclusions: Although research on vulnerable populations as a subgroup is abundant, it fails to report on the
interventions that will actually reduce inequities and consider how redistribution of health care resources could
shrink the gap between the privileged and most vulnerable groups including minorities. Research, if aiming at
being responsive to global health policy trends, needs to report not only on specific attributes but also on how
a better redistribution of health care resources could contribute to alleviating the unjust situation of the most
vulnerable populations.
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Research in context
Evidence before this study
We searched for published Systematic Reviews (SR)
related to vaccination issues (e.g. Oyo-Ita 2011) and
looked for evidence on interventions to reduce inequi-
ties. However, despite that the SR could focus on vulner-
able populations, there was hardly any report on
differential measures between groups to describe how
equity could be improved. This lack of evidence on
differentials would be a serious gap to informing global
policies and their contribution to the Sustainable
Development Goals.
Added value of this study
In order to verify to which extent this lack of evidence
was real, we carried out an overview of systematic reviews
containing vaccination outcomes, scrutinising whether
these reviews did or did not report on equity issues.
We confirmed that despite the wealth of research on
vulnerable groups there were two gaps in research: (1)
while some ‘generic’ groups of vulnerable populations
(e.g. the poor) are widely studied, minorities and other
well-known disadvantaged groups (e.g. low educational
status) are not. (2) Research reports on the effects of
interventions in some vulnerable groups but hardly on
actually reducing differences between the privileged
populations and vulnerable ones on how to better redis-
tribute health care, hence reducing inequities.
Implications of all available evidence
Standard research methods should be developed and en-
couragement given to use these to measure the effects of
interventions that will potentially be useful in reducing
inequity. Policy makers should demand better guidance
not only on what works in vulnerable populations but,
on how to be responsive to the unjust distribution of
health and health care resources.
Introduction
Equity in health is a fundamental moral and ethical
commitment to reduce and eliminate unfair and unjust
disparities in health and its determinants [1]. Health
equity has been at the heart of international initiatives of
human development for decades. [2]. With the recent
declaration of the Sustainable Development Goals
(SDG), communities, social entities, Non-Governmental
Organisations, multi-lateral organisations, academia and
other actors have repeatedly acknowledged the relevance
of equity to ensure sustainable development [3]. Vaccin-
ation is no exception as it will target the whole popula-
tion at several stages in life.
Data from WHO estimates based on administrative
reporting and surveys, and data from large, good quality
Demographic and Health Surveys, point at the same
direction: while vaccination coverage of various antigens
has steadily increased globally in the past decades, it has
recently stagnated at 85% or 86% globally [4] (third dose
of Diphtheria – Tetanus – Pertussis vaccine –DTP3;
WHO estimates) and reached 76% [5] (DTP3 in 2015,
WHO estimates) in the African Region. However, this
progress has been unequal in different countries [6] and
a considerable proportion of children remains partially
or not fully vaccinated [7]. Factors like family income,
education or geographic location are still associated with
different vaccination coverage rates [8], especially in
Low and Middle Income Countries (LMIC) [6]. For ex-
ample, in Mali, immunisation is two times higher in
wealthier households than compared to poor ones, with
this gap widening over 30% in recent years (Demo-
graphic and Health Surveys) [9]. All these data invariable
link low vaccination coverage with less wealth, being it
at international, national or at sub-national levels.
One of the six guiding principles in the Global Vaccine
Action Plan (GVAP) is equity: “equitable access to
immunisation is a core component of the right to
health”[10]; reducing disparities in immunisation, typic-
ally measured with vaccination rates, means that every
eligible individual is vaccinated. Other principles in the
GVAP refer to strategies consistent with the reduction
of inequities; such as shared responsibility between vac-
cination partners and sustainability principles. There are
four compelling arguments to reduce inequities in vac-
cination outcomes [11]. Firstly, access to vaccinations is
a component that contributes to a person being assured
of their human rights to health. Even for the more
recently introduced vaccines [12] vaccines are a cost-
effective intervention to reduce childhood morbidity and
mortality. As such vaccinations (and health care in gen-
eral) have to be seen as social and human assets which
move in the direction of justice and equity. [13]. Thirdly,
the potential benefit of reaching the unreached would be
significantly higher as compared with the general popu-
lation by making individuals and households healthier
[10]; Lastly, other health care interventions can synergise
with outreach and inreach vaccination programmes by
mutually facilitating access to common population
targets [14]. Strikingly, in a review of 62 vaccination
country multi-year plans [15], we found few references
to inequities in vaccination coverage, except for the case
of Ethiopia which had clearly formulated an objective of
reducing the percentage of unimmunised children.
Although there is already a variety of “universal” and
“targeted” interventions to reduce inequities in vaccin-
ation, often reported in terms of coverage; evidence on
the effectiveness of these interventions to reduce the gap
between populations accessing services and those with
substantial barriers to receiving health care seems inad-
equately addressed. Vaccination coverage has been used
Bosch-Capblanch et al. International Journal for Equity in Health  (2017) 16:95 Page 2 of 10
for decades to report vaccination programmes perform-
ance. Recent analyses suggest as well that coverage esti-
mates (including vaccination coverage) are promising
indicators to track health determinants nationally and
internationally [16]. Several Cochrane reviews have
examined the effects of interventions to improve vaccin-
ation coverage but without investigating or finding their
effects across different population groups [17–19].
Målqvist looked at equity issues in targeted interventions
in LMIC [20] but only in relation to measles.
While research describing the health status of vul-
nerable groups is abundant, research on interventions
that impact on their health is less prominent. Yet, if
health policies have to address inequities, evidence,
not only on what works for the most vulnerable, but
on what interventions can actually reduce the in-
equity gaps, is required.
Through an overview of systematic reviews (SRs) in
the area of vaccination the aim of this work is to
describe how globally research on the effects of inter-
ventions on vaccination coverage has targeted vulner-
able populations, and particularly which research
exists on interventions to reduce inequity gaps. We
believe that the wealth of systematic reviews on the
effects of interventions to improve vaccination out-
comes should portray a comprehensive picture of past
and current research on the topic.
Methods
1) Criteria for considering systematic reviews for this
overview
We conducted an overview of SRs. We searched for and in-
cluded any SR aiming at describing the effects of interven-
tions to improve vaccination related outcomes, without
limitations in the type of participants (i.e. receivers of vac-
cination, caregivers, health care providers and managers),
type of intervention, type of vaccine involved or outcome
(i.e. morbi-mortality, coverage rates, behaviours, know-
ledge). We focused on vaccination coverage outcomes be-
cause these are widely used to report on vaccination
programmes performance [21] in the understanding that
inequities in vaccination coverage may reflect inequities on
underlying issues (such as education, wealth or access to
health care). Under the term ‘coverage’ we include as well,
vaccination timeliness and completeness.
The tasks of deciding on relevance, applying the inclu-
sion criteria and data extraction were singly done and
distributed among co-authors of this article. Co-authors
regularly cross-checked the decisions made in a sub-
sample of SR, especially when potential inconsistencies
were identified in the data extracted.
We decided that an article was an SR if it reported a
search strategy, search terms, at least one literature
source, inclusion criteria, types of participants and
interventions. Reviews of a wider scope than that of
vaccination (e.g. preventive measures in general) but
containing vaccination data were equally considered.
We excluded systematic reviews which only included
descriptive studies (e.g. results of Demographic and
Health Surveys) because these studies do not provide
findings on the effects of interventions to improve
vaccination. However, if a systematic review contained
studies which used Demographic and Health Surveys to
report the effects of interventions, this was included.
2) Literature searches
We searched for published SRs, without limits on the
year of publication and language, in the following
electronic bibliographic databases: Medline, EMBASE,
PsycInfo, Cochrane, Web of science, CINAHL and
Ebsco; with terms related to vaccination, immunisa-
tion, systematic review and meta-analyses (and their
variant terms). The original search was carried out in
2013 and was updated in November 2014 including
‘PDQ‐evidence’ [22], an online literature platform to
search SRs and to link with primary studies. See
Additional file 1 for an example of search strategy.
3) Data collection
Duplicate references were removed and studies were
assessed for relevance using titles and abstracts. Full
text relevant articles were screened using the inclu-
sion criteria described. Data was extracted using a
standard template and included reference information,
SRs data (e.g. number of studies in the SR), partici-
pants, interventions, comparators, equity groups and
effects estimates. We classified interventions into the
following broad categories: delivery of care, financial,
human resources, Information, Education and Com-
munication (IEC), infrastructures, organisation and
regulations and substance or device. Other interven-
tions or combinations of interventions were cate-
gorised as ‘other’. Data was extracted as reported and
we used data from individual studies when data was
not pooled in SRs. Inclusion and data extraction were
carried once with regular checks from the most se-
nior authors and additional data checks were set up
to verify extracted effect estimates. We considered
data reported in any form: absolute differences,
relative differences and changes in time of the inter-
vention groups.
4) Consideration of equity in systematic reviews
Equity can be considered under two perspectives: as
interventions specifically targeting vulnerable groups
(‘targeted interventions’) or as interventions for the
whole population but the effects of which are only mea-
sured in vulnerable groups [23]. However, it was hardly
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possible to identify this feature in the objectives of the
SR or primary studies. Data on equity was extracted
following PROGRESS‐plus [24], which stands for
Place of residence; Race/ethnicity, Occupation, Gen-
der, Religion, Education, Socioeconomic status (SES),
Social capital, ‘plus’ age, disability and the sexual
orientation. We also captured and categorised as
‘other’ attributes which reviews’ authors would relate
to vulnerability (e.g. groups of subjects with chronic
conditions). Where available we extracted differences
or gradients of effects in equity groups.
5) Quality of included systematic reviews
We assessed the methodological quality of the SRs using
a combination of the tool ‘Assessing the Methodological
Quality of Systematic Reviews’ (AMSTAR [25]) and the
tool ‘Preferred Reporting Items for Systematic Reviews
and Meta-Analyses’ (PRISMA‐equity version [26]).
PRISMA-equity is a tool to assist reviewers to report on
reviews addressing equity issues and provides criteria to
assess the reporting quality of SR. These are widely ac-
cepted tools to assess the methodological and reporting
quality of SR, respectively. Besides assessing the quality
of included SRs, we did not reassess the quality of the
studies included in those SRs, which were carried out by
the SRs’ authors in the first instance.
6) Analyses
The units of analyses in this overview were data points
or ‘comparisons’, considering together data from the
same types of participants, interventions and outcomes.
We did not attempt to pool data or carry out meta-
analyses due to (i) the large heterogeneity in the types of
comparisons; (ii) the frequent lack of data to allow
meta-analyses (e.g. number of participants or number of
studies) and (iii) the different ways SR reported their
findings (e.g. sometimes as pooled estimates and some-
times as single study effects).
To describe the research landscape of systematic re-
views addressing equity issues, we present counts and
percentages of comparisons by equity attributes.
Results
The literature databases searches yielded 2,003 hits.
After removing 694 duplicates, the remaining 1,309 re-
cords were screened for relevance. 162 articles were
assessed for inclusion of which 54 were finally included
(see Fig. 1). These 54 SRs were those which complied
with the inclusion criteria; namely having followed SR
methods and reported one vaccination coverage related
outcome. The references of included SRs, the character-
istics of included SRs and excluded SRs and reasons for
exclusion can be found in the Additional file 1: 1 to 3
respectively.
Publication years of included SRs ranged from 1994 to
2014 (median 2008). The oldest study included in the
SRs dated from 1950. Studies in SRs were randomised
controlled trials (RCT) (29.3%), cluster randomised
controlled trials (CRCT) (17.9%) and less frequently
controlled before and after (CBA) studies (6.3%) and
interrupted time series studies (5.2%). The rest of study
designs were observational with and without controls.
SRs and studies within them expanded across all conti-
nents. Fifty-six percent of the SRs referred to studies
conducted in High Income Countries (HIC), 30% in
Middle Income Countries and 14% in Low Income
Countries.
The quality of the SRs varied greatly (Table 1). The
three most frequent criteria with positive assessments
were those reporting on the number of included studies,
the sources of studies and the risk of bias method used.
The three most frequent criteria with negative
assessments were those that lacked (i) a list of excluded
studies, (ii) a reporting on the existence of a protocol for
the SRs and (iii) information whether or not researchers
were contacted.
Fig. 1 Flow of Systematic Reviews screening and inclusion
Bosch-Capblanch et al. International Journal for Equity in Health  (2017) 16:95 Page 4 of 10
Among the 54 SRs, participants were providers
(24.1%), caregivers (18.5%), subjects targeted by vaccin-
ation (9.3%) or other groups (3.7%). In two other SRs,
participants were not described (3.7%). In 22 SRs
(40.7%) participants were a combination of the above,
including subjects targeted by vaccination.
Twenty‐four of the 54 included SRs reported on more
than one intervention. The types of interventions, by de-
creasing frequency were: ‘processes’ (18.5%), financial,
substance or device (7.4%), human resources (3.7%) and
organisational interventions (1.9%). The remaining four
SRs (7.4%) reported other interventions. Comparators
were regular care (46.3%), combination of other inter-
ventions (20.4%), financial (3.7%) and process interven-
tions (1.9%). Two SRs reported other comparators
(3.7%). Noteworthy, 12 SRs did not report a comparator
(22.2%); they included only observational studies.
We extracted 2,568 data points, including effect
estimates and individual data points used for those
estimates, where available, of which 1,288 reported
some type of effect of interventions and considered as
‘comparisons’. The number of data points or compari-
sons included in this analysis varies because not all
the comparisons had complete information on inter-
ventions and outcomes.
The most frequently reported outcome was vaccin-
ation coverage expressed as rates for a specific vaccine,
completion of vaccination schedules or timely vaccin-
ation. Knowledge (e.g. about vaccination schedule or
other aspects of vaccination) was reported for all vaccine
groups except for Human Papilloma Virus (HPV) and
Tetanus Toxoid (TT). Morbidity and mortality was re-
ported for the Expanded Programme of Immunisation
(EPI) vaccines as well as for other vaccines. Vaccines
reported were influenza (44% of data points), vaccines
included in the EPI (34%), Pneumococcal Conjugate
Vaccine (PCV) (13%), HPV (2%), and TT (1%). Other
vaccines (4.6%) included Varicella Vaccine or combina-
tions of the above.
Of the 1,153 comparisons which had effect estimates,
effects were reported as favouring the intervention in
the vast majority of comparisons: 44.6% and 47.3%, with
and without statistically significant estimates, respect-
ively. The control group was favoured in 7.7% of the
comparisons and neither positive nor negative effects
were reported in 0.4% comparisons.
Of the 54 SRs, 17 (31.5%) explicitly referred to equity
groups within their method sections: six of them focused
on socio‐economic status (SES), two referred to age
groups, six contained a combination of equity attributes
and three referred to other categories. However, even re-
views which did not explicitly refer to equity in its text
might contain data about equity groups (see Table 2).
The most common equity group found was ‘place of
residence’, which included rural and urban subgroups
but also data from different subnational areas, and a
Table 1 Frequencies of the qualtiy criteria of the included
Systematic Reviews (from PRISMA and AMSTAR)
PRISMA Yes Unclear No
SR in title 47 87.0% 1 1.9% 6 11.1%
Rationale 51 94.4% 2 3.7% 1 1.9%
Question 33 61.1% 1 1.9% 20 37.0%
Protocol 14 25.9% 8 14.8% 32 59.3%
Sources 53 98.1% 0 0.0% 1 1.9%
Search 39 72.2% 0 0.0% 15 27.8%
Selection 28 51.9% 3 5.6% 23 42.6%
Data extraction 30 55.6% 1 1.9% 23 42.6%
Researchers contacted 19 35.2% 8 14.8% 27 50.0%
Data variables 27 50.0% 3 5.6% 24 44.4%
Risk of bias method 51 94.4% 0 0.0% 3 5.6%
Type of measures 35 64.8% 2 3.7% 17 31.5%
Synthesis methods 30 55.6% 0 0.0% 24 44.4%
Limitations 33 61.1% 0 0.0% 21 38.9%
Funding 36 66.7% 1 1.9% 17 31.5%
N screened or relevant 49 90.7% 0 0.0% 5 9.3%
N included 53 98.1% 0 0.0% 1 1.9%
Sources grey 19 35.2% 9 16.7% 26 48.1%
List included 43 79.6% 2 3.7% 9 16.7%
List excluded 8 14.8% 2 3.7% 44 81.5%
Conflict of Interest 29 53.7% 2 3.7% 23 42.6%
Table elaborated by the authors based on the quality assessments of
Systematic Reviews
Table 2 Number and percentage of Systematic Reviews with
data referred to equityattributes
Attributes Number of reviews with at least 1 factor
Place of residence 29 53.7%
Race/Ethnicity 10 18.5%
Occupation 15 27.8%
Gender 13 24.1%
Religion 2 3.7%
Education 4 7.4%
SES 16 29.6%
Social capital 5 9.3%
Disability 14 25.9%
Sexual orientation 2 3.7%
Other 29 53.7%
Total 54 100.0%
Table elaborated by the authors based on the data extracted from
Systematic Reviews
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miscellaneous group which included, for example, par-
ticipants vaguely defined as ‘high-risk’, or veterans. SES,
occupation, disability and gender were found in slightly
more than 20% of SRs. Religion, sexual orientation and
education were the least frequently found.
Looking at more detail on how equity issues are re-
ported in comparisons within SRs, Table 3 represents
the relative frequency of each attribute over the whole
equity criteria by decade, region and intervention.
There does not seem to be a clear overall tendency of
an equity attribute to stand out over the others by dec-
ade, except for the gender attribute which seemed to be
more prominent in the last decade (in 17% comparisons)
than in previous decades (0.0 to 6.0%). Contrarily, two
attributes seemed less frequently reported in the last
decade: occupation and the ‘other’ attribute. It has to be
noted that the number of data points in the last decade
was lower than before, reflecting the time lapse required
to incorporate recent research into SRs.
The most frequently reported attribute was ‘place of
residence’ in SRs with studies from Africa, Latin Amer-
ica and Caribbean and in Asia. On the other hand,
‘disability’ was the most frequent (‘other’ apart) in North
America, Europe and Oceania. The few comparisons in-
volving sexual orientation were from North America and
the few on religion from Asia. The relative frequency of
‘gender’ over all groups was higher in Asia than in other
regions.
Looking at the type of intervention, the most common
comparisons were related to the delivery of care, finan-
cial interventions, IEC and a miscellaneous group. Place
of residence was the first or second most frequently en-
countered attribute in these comparisons in all types of
interventions. Predominant groups in the delivery of
care interventions were gender, ‘place of residence’, SES
and disabilities. IEC interventions were implemented ac-
cording to the ‘place of residence’, in people with disabil-
ities, in occupation subgroups and in others. As could
be expected, the most frequent group for financial inter-
ventions was the SES.
The great majority of SRs and studies within them did
not estimate differentials or gradients across equity attri-
butes, except for a few studies. Usman 2009 (in SR Kauf-
man 2013) was a RCT on the effects of face-to-face
Table 3 Percentages of data points for each equity attribute, by decade, geographical region and type of intervention
Group Place of
residence
Race,
ethnicity
Occupation Gender Religion Education SES Social
capital
Disability Sexual
orientation
Other Data
points
Data
points
equity
By decade
1976 to 1984 20.0% 6.0% 25.0% 0.0% 0.0% 0.0% 14.0% 0.0% 55.0% 0.00% 41.0% 82 51
1985 to 1994 19.0% 2.0% 23.0% 6.0% 0.0% 0.0% 5.0% 0.0% 20.0% 0.00% 45.0% 360 296
1995 to 2004 25.0% 5.0% 12.0% 5.0% 1.0% 1.0% 13.0% 1.0% 26.0% 0.02% 54.0% 633 443
2005 to 2014 18.0% 4.0% 9.0% 17.0% 0.0% 0.0% 13.0% 1.0% 28.0% 0.00% 17.0% 183 174
By region
Africa 39.0% 2.0% 0.0% 10.0% 0.0% 0.0% 20.0% 2.0% 5.0% 0.00% 10.0% 52 59
Asia 58.0% 0.0% 22.0% 38.0% 4.0% 1.0% 7.0% 4.0% 7.0% 0.00% 19.0% 111 69
Europe 4.0% 2.0% 17.0% 7.0% 0.0% 0.0% 4.0% 0.0% 19.0% 0.00% 42.0% 133 140
LAC 43.0% 0.0% 0.0% 11.0% 0.0% 0.0% 34.0% 0.0% 0.0% 0.00% 2.0% 40 44
North America 22.0% 10.0% 15.0% 4.0% 0.0% 0.0% 14.0% 0.0% 29.0% 0.02% 47.0% 979 689
Oceania 8.0% 0.0% 3.0% 14.0% 0.0% 3.0% 11.0% 0.0% 25.0% 0.00% 44.0% 39 36
By intervention
Delivery, care 19.0% 5.0% 6.0% 24.0% 0.0% 0.0% 15.0% 0.0% 15.0% 0.00% 33.0% 167 142
Financial 16.0% 1.0% 5.0% 1.0% 0.0% 0.0% 13.0% 0.0% 12.0% 0.00% 22.0% 96 136
Human resources 38.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00% 0.0% 3 8
IEC 21.0% 5.0% 16.0% 5.0% 0.0% 0.0% 10.0% 1.0% 21.0% 0.00% 38.0% 767 650
Infrastructures 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00% 100.0% 4 4
Organisation,
regulations
6.0% 3.0% 3.0% 0.0% 0.0% 0.0% 6.0% 0.0% 16.0% 0.00% 3.0% 12 31
Other 21.0% 10.0% 23.0% 3.0% 0.0% 2.0% 10.0% 0.0% 27.0% 0.00% 34.0% 404 311
Substance/
device
100.0% 0.0% 0.0% 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00% 100.0% 9 3
Sums of rows may add up to more than 100% because more than one equity group may be reported in the same comparison
Table elaborated by the authors based on the data extracted from Systematic Reviews
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interventions to improve diphtheria-tetanus-pertussis
coverage in Pakistan. The study compared urban and
rural areas with Odds Ratios (OR) of 1.18 (95CI: 1.05 to
1.33) and OR 1.54 (95CI: 1.33 to 1.79) favouring the in-
terventions, respectively. La Montaigne 2011 (in SR Paul
2014) was an observational study in India comparing the
third dose of HPV vaccine coverage in urban, rural and
tribal areas, with before and after changes ranging from
68.1 to 77.2%, from 83.3 to 87.8% and from 71.1 to
68.1%, respectively. Cuttes 1988 (in SR Ryman 2008) was
another observational study in Mozambique assessing
the effects of visiting homes to mobilise the community
on fully vaccinated children in four areas of residence,
with changes in coverage ranging from −4 to 33%. Cutts
1990 (in SR Shea 2009) was a study using different
methodological approaches assessing outreach, commu-
nication, training and volunteers activities to improve
measles vaccination in four locations, showing changes
in coverage ranging from 1 to 31%.
Discussion
We have carried out an overview of SRs containing
information related to vaccination, looking for equity
attributes as explicitly described by authors or as
found using the PROGRESS-plus groups. We exam-
ined the area of vaccination under a very wide per-
spective not limiting SRs according to study designs,
participants, interventions or outcome, which gives a
comprehensive view of a key public health area. We
are not aware of any other global overview describing
how research has reported evidence on interventions
to improve vaccination outcomes from an equity
perspective, although there are examples of SRs on
interventions to reduce inequities in specific groups,
such as immigrants [27], or through health systems
interventions [28], or studies describing the distribu-
tion of equity attributes among populations [5, 29].
Research evidence predominates in certain HIC,
mainly in relation to influenza vaccination, addressing
a limited scope of equity attributes and with scarcity
of studies which show changes in equity gaps or
gradients between population subgroups.
This overview suggests that equity attributes were
widely but inconsistently represented in the scientific
literature. There was a predominance of research
carried out in North America with many studies
focusing on influenza vaccines. These studies did not
seem particularly more focused on equity issues as
compared with studies from other regions or with
other vaccines. However, research on vaccines admin-
istered at different ages (e.g. routine childhood vac-
cination as compared to influenza vaccination) may
uncover age-specific challenges in accessing vaccin-
ation; similarly with different countries and settings.
These differences did not particularly emerge in this
overview of SRs, which could be precisely due to the
fact that research is not really focusing on equity
attributes but rather on subjects who happened to
belong to different subgroups of population.
The identification of equity attributes may be due to
the fact that equity has been actively promoted by the
international community [30]. We would therefore ex-
pect an increased awareness on equity among re-
searchers in recent years, which could have been
captured by the fact of not having put any time limit in
the search for SRs. However, this has not necessarily led
to uniform improvements in equity in the last decade,
especially in LMIC [31, 32]. Additionally, the
PROGRESS-plus groups cover such a very wide range of
situations that it should not be difficult to find studies
and SRs on equity attributes. This is not striking as such
because, most of the population in the globe are living
in LMIC or are poor [33, 34] and it is not difficult to
find a study which involves these sectors of the popula-
tion. However in our overview, besides the attributes
‘place of residence’ and ‘other’, the presence of equity at-
tributes was much more modest and severely scarce in
some. Research from LMIC where much of the burden
of disease is [35] and where vaccination coverage rates
are lower [36], is less abundant and not particularly
focused on equity. It is striking for example, that despite
consistent evidence that the level of education of
caregivers is negatively related to vaccination status in
LMIC [37], education is one of the least addressed
equity factors we could find. One explanation for this
could be the ethical dilemmas of carrying out compara-
tive studies in which one control or comparison group
would not benefit from a basic educational intervention,
such as literacy education.
Inequity is not about being in a given level of SES or
in a gender group, but a matter of ‘differences’ and has
an intrinsic ethical dimension; it is about justice [38, 39].
Actually inequities point to the fact that disadvantages
in some human groups are directly related to privileges
in other groups. Targeted interventions may have an im-
pact on improving the health of vulnerable populations
[12]; yet, this does not necessarily imply reducing
differences and improving equity. In most of the evi-
dence we retrieved, interventions had vulnerable groups
as participants, but they did not seem to be specifically
designed to address the gaps in health and health care
between disadvantaged and privileged groups, as re-
ported by authors. Studying the poor or the vulnerable,
being essential and desirable, does not necessarily pro-
vide evidence on the key issues of how inequities can be
reduced [40], or how health and health care resources
can be better redistributed. It is striking that examples of
analyses of group differences, which could very well
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inform approaches to better redistribute health care
resources, i.e. estimates of effects between privileged and
vulnerable populations, were hardly found and those
that were, were of a reduced scope. While some disad-
vantaged groups are the largest majority, other vulner-
able populations are actually minorities, e.g. transsexual
people [41] or prisoners [42], and as expected they are
much less present in the research we examined. The fact
that some of these disadvantaged groups are actually mi-
norities may be a contributing factor for not having been
extensively studied..
We acknowledge that research on equity may pose
methodological challenges [43], which could explain the
relative lack of comparators in a large proportion of the
underlying (observational) studies, confirmed in the
findings of a recent review [44]; for example, larger
sample sizes may be needed to allow comparisons be-
tween subgroups or study settings and implementation
may need more resources and time. Mortality and life
expectancy differentials, as proposed to monitor SDG
[45], are examples of methodological challenges which
may contribute to ‘discourage’ the equity focus in indica-
tors related to universal health coverage [46].
Furthermore, the heterogeneity of approaches limits
the capacity to compare strategies to reduce inequity in
different health care fields and contexts. Therefore,
equity definitions such PROGRESS-plus need to be ur-
gently complemented with the development of robust
and realistic methods to measure inequities in health
care [47] both at macro and micro levels. Besides, agree-
ment across research areas on critical equity outcomes
would benefit further efforts to conduct research synthe-
sis on inequities [48].
Another issue to be considered is that critical equity
attributes may be different in nature and importance in
different types of health problems. In the area of vaccin-
ation, the age groups and settings to deliver influenza
vaccine greatly differ from routine childhood vaccina-
tions. This is also more the case in other health areas.
For example, children and the productive age group have
been associated with fatalities in road traffic accidents,
especially in LMIC.
Our overview had several limitations. First, inclusion
criteria and data extraction was single-applied, which
may have increased the chances of errors, which we
cannot exclude despite the controlling mechanisms we
put in place while carrying out the work. However, we
believe that this could hardly have any impact in the
main conclusions of this overview. Neither could we rule
out duplicate reporting if primary studies were included
in more than one of the included SRs, since some of the
SRs did not contain a full list of references. Secondly, we
actually found poor reporting in SRs and in the studies
contained in them and this was our subjective impression
when reading the articles. Poor reporting jeopardises the
capacity to produce sound evidence on equity, which
requires some additional details in the description of inter-
ventions, outcomes and implementation approaches.
Conclusion
Equity (and inequities) is a top priority issue in the hu-
man health development agenda [49] and an entry point
to install clear ethical directions in the redistribution of
health and health care. Often, it is not the most margin-
alised that receive assistance, as indicated in a recent
overview on official development assistance [50]. While
the amount of descriptive research on the status of the
most vulnerable population is overwhelming and there is
also abundant research on interventions to improve vac-
cination outcomes, our overview identified two gaps: (a)
research on specific minority groups (e.g. religious or
groups defined by sexual orientation) and (b) research
on what works, not only to improve health outcomes in
general, but to close the inequity gaps between the privi-
leged and the vulnerable populations: how to effectively
redistribute health among the different layers or society.
This is essential to inform national and international
choices which affect the access of the most vulnerable
(being they majorities or minorities) to the health care
that others already enjoy. Research and policy, if wishing
to remain relevant, should mirror the unbearable suffer-
ing of disadvantaged human beings by prioritising the
production of robust evidence on what affects them, no
matter how many they are or where they live.
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